CASR and colorectal cancer: In this context,receptor agonists represent interesting candidates for the treatmentof colorectal cancer.255 Indeed, elevatedintake of dietary calcium has been associated with reduced risk ofcolon cancer.256 In general, calcium levelsand calcium signaling are altered in cancer cells.257 Signaling via these CaSR can determine cell fate, whichmakes them attractive potential therapeutic targets.